'We now have the clinical data package to support global submissions for retatrutide as a potential treatment for obesity, knee osteoarthritis pain, and obstructive sleep apnea.'

New research highlights the persistence of sleep issues following the end of COVID-19 lockdowns, regardless of infection history.

For many Americans, a good night's sleep is easier said than done. According to a survey from the American Academy of Sleep Medicine, the pressures of daily life impact how well adults sleep. Topping the list, nearly hal...

The $75,000 grant from the Resmed Foundation will fund a clinical research project examining how obstructive sleep apnea impacts recovery in inpatient rehabilitation settings.

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. CMS proposed rule: Physician fee schedule CMS has re...

New data from a long-term extension study demonstrates sustained improvements in wakefulness, cognition, and fatigue for adults with narcolepsy type 1 and type 2.

Incannex Healthcare has initiated screening for its DReAMzz dose confirmation study evaluating IHL-42X for obstructive sleep apnea.

On July 14, the Centers for Medicare & Medicaid Services (CMS) released the 2027 physician fee schedule (PFS) proposed rule. The proposal includes payment updates, telehealth policies, and several initiatives that co...

On July 12, Pennsylvania Governor Josh Shapiro signed into law HB 1505, a state budget package, which included a provision permitting school districts to redirect existing funding streams, to cover the costs of planning,...

The oral orexin 2 receptor agonist currently in phase 1b development for patients with narcolepsy.